efavirenz has been researched along with Meningitis, Cryptococcal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| George, PE; Mercedes, R; Nabukeera-Barungi, N; Otto, SBJ | 1 |
| Abgrall, S; Arribas, JR; Barger, D; Barrufet, P; Braun, D; Caniglia, EC; Cardoso, SW; Chrysos, G; Costagliola, D; Gill, J; Gogos, C; Hauser, C; Hernán, MA; Hoyos, SP; Justice, A; Leyes, M; Lodi, S; Logan, R; Meyer, L; Moreno, S; Muga, R; Pacheco, A; Phillips, A; Porter, K; Reiss, P; Sabin, CA; Seng, R; Tate, J; van Sighem, A; Vandenhende, MA; Winston, A | 1 |
| Boulware, DR; Lukande, R; Meya, DB; Namuju, OC; Nicol, MR; Pastick, KA; Rhein, J; Taylor, J; Williams, DA | 1 |
| Alanio, A; De Castro, N; Gaube, G; Gueguen, A; Lascoux, C; Molina, JM; Zagdanski, AM | 1 |
| Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P | 1 |
| Back, D; Dickinson, L; Watson, V; Yilmaz, A | 1 |
| Bellamy, S; Bisson, GP; Gluckman, S; Molefi, M; Rantleru, T; Ravimohan, S; Steenhoff, A; Tamuhla, N; Tebas, P; Thakur, R; Tsimako, I; Weissman, D | 1 |
| Bowonwatanuwong, C; Chantratita, W; Chetchotisakd, P; Mootsikapun, P; Sungkanuparph, S; Tansuphaswaswadikul, S; Vibhagool, A | 1 |
2 trial(s) available for efavirenz and Meningitis, Cryptococcal
| Article | Year |
|---|---|
Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Colony Count, Microbial; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Organophosphonates; Survival Analysis; Tenofovir; Treatment Outcome | 2013 |
Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cryptococcus neoformans; Cyclopropanes; Female; HIV; Humans; Male; Meningitis, Cryptococcal; Oxazines; RNA, Viral; Thailand; Time Factors | 2003 |
6 other study(ies) available for efavirenz and Meningitis, Cryptococcal
| Article | Year |
|---|---|
Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Benzoxazines; Child; Cryptococcus neoformans; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Female; Fluconazole; HIV; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Lopinavir; Meningitis, Cryptococcal; Ritonavir; Treatment Outcome; Viral Load; Zidovudine | 2020 |
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Alkynes; Americas; Atazanavir Sulfate; Benzoxazines; Cohort Studies; Cyclopropanes; Darunavir; Europe; Female; HIV Protease Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Lopinavir; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Toxoplasmosis | 2018 |
Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis.
Topics: Alkynes; Benzoxazines; Brain; Creatinine; Cyclopropanes; Humans; Lamivudine; Meningitis, Cryptococcal; Postmortem Changes; Tenofovir | 2019 |
Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis.
Topics: Adalimumab; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cameroon; Combined Modality Therapy; Cyclopropanes; Delayed Diagnosis; Drug Therapy, Combination; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Meningitis, Cryptococcal; Prednisone; Stavudine; Tumor Necrosis Factor-alpha; Ventriculoperitoneal Shunt | 2016 |
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Efavirenz pharmacokinetics in cerebrospinal fluid and plasma over a 24-hour dosing interval.
Topics: Alkynes; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Benzoxazines; Chromatography, High Pressure Liquid; Coinfection; Cryptococcus neoformans; Cyclopropanes; Half-Life; HIV; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Tandem Mass Spectrometry | 2012 |